Zoetis Inc. $ZTS Shares Sold by Texas Permanent School Fund Corp

Texas Permanent School Fund Corp cut its stake in shares of Zoetis Inc. (NYSE:ZTS) by 11.3% during the second quarter, Holdings Channel reports. The firm owned 52,440 shares of the company’s stock after selling 6,667 shares during the quarter. Texas Permanent School Fund Corp’s holdings in Zoetis were worth $8,178,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Brighton Jones LLC increased its position in shares of Zoetis by 180.4% in the fourth quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock worth $754,000 after acquiring an additional 2,978 shares in the last quarter. Raymond James Financial Inc. boosted its stake in Zoetis by 1.8% in the 1st quarter. Raymond James Financial Inc. now owns 1,228,806 shares of the company’s stock worth $202,323,000 after purchasing an additional 21,840 shares during the period. Steward Partners Investment Advisory LLC grew its position in Zoetis by 2.6% during the 1st quarter. Steward Partners Investment Advisory LLC now owns 49,387 shares of the company’s stock worth $8,132,000 after purchasing an additional 1,236 shares in the last quarter. Summit Securities Group LLC acquired a new stake in Zoetis during the 1st quarter valued at $64,000. Finally, Brooklyn Investment Group raised its stake in Zoetis by 8.8% during the 1st quarter. Brooklyn Investment Group now owns 3,978 shares of the company’s stock valued at $655,000 after purchasing an additional 323 shares during the period. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. Argus reaffirmed a “buy” rating and issued a $190.00 target price on shares of Zoetis in a research report on Tuesday, September 9th. JPMorgan Chase & Co. reduced their price objective on Zoetis from $230.00 to $200.00 and set an “overweight” rating for the company in a research note on Wednesday, November 5th. Bank of America lowered Zoetis from a “buy” rating to a “neutral” rating and set a $135.00 price objective for the company. in a research report on Monday. HSBC set a $140.00 target price on Zoetis in a report on Wednesday, December 10th. Finally, The Goldman Sachs Group upgraded shares of Zoetis to a “buy” rating in a report on Monday. Six equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $161.55.

Zoetis Trading Up 2.0%

NYSE:ZTS opened at $121.08 on Tuesday. The company has a market capitalization of $53.36 billion, a P/E ratio of 20.38, a P/E/G ratio of 2.46 and a beta of 0.97. The stock’s 50 day moving average price is $130.46 and its 200 day moving average price is $145.62. The company has a debt-to-equity ratio of 1.31, a quick ratio of 2.28 and a current ratio of 3.64. Zoetis Inc. has a 52 week low of $115.25 and a 52 week high of $179.29.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping the consensus estimate of $1.62 by $0.08. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The company had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.42 billion. During the same period in the previous year, the firm posted $1.58 earnings per share. The company’s revenue for the quarter was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, research analysts forecast that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 3rd. Shareholders of record on Tuesday, January 20th will be issued a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 1.8%. This is an increase from Zoetis’s previous quarterly dividend of $0.50. The ex-dividend date is Tuesday, January 20th. Zoetis’s dividend payout ratio is 35.69%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.